Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV130 vs Morphine and Placebo in Healthy Men
NCT02083315Phase 1Completed
- Sponsor
- Trevena, Inc.
- Start
- Jul 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oliceridine in acute pain (5 arms), sponsored by Trevena, Inc. Primary endpoint: Cold Pain Test Latency. Started Jul 2013; status: completed.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02083315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083315.